GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » ROE % Adjusted to Book Value

Vita Life Sciences (ASX:VLS) ROE % Adjusted to Book Value : 10.67% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Vita Life Sciences ROE % Adjusted to Book Value?

Vita Life Sciences's ROE % for the quarter that ended in Dec. 2023 was 24.65%. Vita Life Sciences's PB Ratio for the quarter that ended in Dec. 2023 was 2.31. Vita Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 10.67%.


Vita Life Sciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Vita Life Sciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences ROE % Adjusted to Book Value Chart

Vita Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.45 11.76 8.77 10.07 9.83

Vita Life Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.32 7.51 9.32 9.38 10.67

Competitive Comparison of Vita Life Sciences's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vita Life Sciences's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Vita Life Sciences's ROE % Adjusted to Book Value falls into.



Vita Life Sciences ROE % Adjusted to Book Value Calculation

Vita Life Sciences's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=22.71% / 2.31
=9.83%

Vita Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=24.65% / 2.31
=10.67%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vita Life Sciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Vita Life Sciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita Life Sciences (ASX:VLS) Business Description

Traded in Other Exchanges
N/A
Address
Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region.

Vita Life Sciences (ASX:VLS) Headlines

No Headlines